Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily

被引:35
|
作者
Baxter, RC
Binoux, MA
Clemmons, DR
Conover, CA
Drop, SLS
Holly, JMP
Mohan, S
Oh, Y
Rosenfeld, RG
机构
[1] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA
[2] Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia
[3] Hop St Antoine, INSERM, U142, F-75571 Paris, France
[4] Univ N Carolina, Sch Med, Dept Med, Div Endocrinol, Chapel Hill, NC 27599 USA
[5] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA
[6] Sophia Childrens Univ Hosp, Div Endocrinol, Rotterdam, Netherlands
[7] Univ Bristol, Bristol Royal Infirm, Dept Surg, Bristol BS2 8HW, Avon, England
[8] Loma Linda Univ, Dept Med, Loma Linda, CA 92357 USA
来源
关键词
D O I
10.1210/jc.83.9.3213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3213 / 3213
页数:1
相关论文
共 50 条
  • [41] Pediatric reference intervals for growth hormone, insulin-like growth factor I, and insulin-like growth factor binding protein-3.
    Wada, DA
    Owen, WE
    Roberts, WL
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (03) : 463 - 464
  • [42] Fluoroquinolones upregulate insulin-like growth factor-binding protein 3, inhibit cell growth and insulin-like growth factor signaling
    Chung, Chih-Ling
    Chen, Chun -Lin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 969
  • [43] Increased insulin-like growth factor binding protein levels in the testes of insulin-like growth factor-I transgenic mice
    Dyck, MK
    Ouellet, M
    Gagne, M
    Sirard, MA
    Pothier, F
    BIOLOGY OF REPRODUCTION, 1997, 56 : 265 - 265
  • [44] INSULIN-LIKE GROWTH-FACTOR-2 AND INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN-2 EXPRESSION IN HEPATOBLASTOMA
    AKMAL, SN
    YUN, K
    MACLAY, J
    HIGAMI, Y
    IKEDA, T
    HUMAN PATHOLOGY, 1995, 26 (08) : 846 - 851
  • [45] Suppression of uterine insulin-like growth factor binding protein 5 by estrogen is mediated in part by insulin-like growth factor I
    Huynh, H
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (02) : 427 - 432
  • [46] Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer's Disease
    Duron, Emmanuelle
    Funalot, Benoit
    Brunel, Nadege
    Coste, Joel
    Quinquis, Laurent
    Viollet, Cecile
    Belmin, Joel
    Jouanny, Pierre
    Pasquier, Florence
    Treluyer, Jean-Marc
    Epelbaum, Jacques
    le Bouc, Yves
    Hanon, Olivier
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4673 - 4681
  • [47] Risk of prevalent and incident dementia associated with insulin-like growth factor and insulin-like growth factor-binding protein 3
    Almeida, O. P.
    Hankey, G. J.
    Yeap, B. B.
    Chubb, S. A. Paul
    Gollege, J.
    Flicker, L.
    MOLECULAR PSYCHIATRY, 2018, 23 (08) : 1825 - 1829
  • [48] INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN IN THE TOAD, BUFO-WOODHOUSEI
    PANCAKROESSLER, MK
    LEE, PDK
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1990, 78 (02) : 263 - 272
  • [49] Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia
    Roberts, RO
    Jacobson, DJ
    Girman, CJ
    Rhodes, T
    Klee, GG
    Lieber, MM
    Jacobsen, SJ
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (09) : 784 - 791
  • [50] Insulin-like growth factor-1 and insulin-like growth factor binding protein 3 and risk of postoperative cognitive dysfunction
    Jiang, Jue
    Chen, Zhifeng
    Liang, Bing
    Yan, Jia
    Zhang, Ying
    Jiang, Hong
    SPRINGERPLUS, 2015, 4 : 1 - 7